Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease

BACKGROUND: Currently available treatments for Alzheimer’s disease (AD) can produce mild improvements in cognitive function, behavior, and activities of daily living in patients, but their influence on long-term survival is not well established. This study was designed to assess patient survival and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hager, Klaus, Baseman, Alan S, Nye, Jeffrey S, Brashear, H Robert, Han, John, Sano, Mary, Davis, Bonnie, Richards, Henry M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3937252/
https://ncbi.nlm.nih.gov/pubmed/24591834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S57909
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak